ABROCITINIB MONOTHERAPY PROVIDES RAPID AND SUSTAINED ITCH IMPROVEMENT AT VARIOUS THRESHOLDS OF RESPONSE IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POOLED ANALYSIS OF THREE RANDOMIZED TRIALS

被引：0
|
作者：
Kwatra, Shawn G. [1 ]
Guttman-Yassky, Emma [2 ]
Biswas, Pinaki [3 ]
Myers, Daniela E. [4 ]
Guler, Erman [5 ]
Gooderham, Melinda J. [6 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA
[2] Icahn Sch Med Mt Sinai, Med Ctr, New York, NY 10029 USA
[3] Pfizer Inc, New York, NY USA
[4] Pfizer Inc, Collegeville, PA USA
[5] Pfizer, Istanbul, Turkey
[6] SKiN Ctr Dermatol, Peterborough, ON, Canada
来源：
ACTA DERMATO-VENEREOLOGICA | 2022年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P2.02
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [1] Depth of response to abrocitinib in adults with moderate-to-severe atopic dermatitis (AD): Pooled analysis of monotherapy studies
    Staender, Sonja
    Bhatia, Neal
    Gooderham, Melinda J.
    Silverberg, Jonathan I.
    Thyssen, Jacob P.
    Biswas, Pinaki
    DiBonaventura, Marco
    Romero, William
    Farooqui, Saleem A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB148 - AB148
  • [2] Impact of abrocitinib on itch, sleep, skin pain and psychological stress in patients with moderate-to-severe atopic dermatitis: pooled analysis from JADE monotherapy trials
    Bewley, A.
    Thyssen, J. P.
    Chiu, W. S.
    Rojo, R.
    Biswas, P.
    Feeney, C.
    DiBonaventura, M.
    Misery, L.
    Stander, S.
    Cork, M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E72 - E73
  • [3] Rapid and sustained improvement in skin pain with abrocitinib in adult and adolescent patients with moderate-to-severe atopic dermatitis
    Thyssen, J. P.
    Bewley, A.
    Stander, S.
    Kim, B.
    Biswas, P.
    DiBonaventura, M.
    Watkins, M.
    Alderfer, J.
    Guler, E.
    Silverberg, J. I.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E150 - E151
  • [4] Lebrikizumab improvement in itch reduction at 52 weeks in patients with moderate-to-severe atopic dermatitis: pooled analysis of two phase 3 randomized controlled trials
    Yosipovitch, Gil
    Lio, Peter
    Rosmarin, David
    Legat, Franz
    Carrascosa, Jose Manuel
    Meskimen, Eric
    Casillas, Marta
    Pierce, Evangeline
    Liu, Zhuqing
    Zhong, Jinglin
    Staender, Sonja
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB188 - AB188
  • [5] Time to improvement in daily signs and symptoms associated with atopic dermatitis (AD) in patients with moderate-to-severe AD in pooled monotherapy studies of abrocitinib
    Gooderham, Melinda J.
    Lebwohl, Mark G.
    Simpson, Eric L.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB120 - AB120
  • [6] Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
    Thyssen, Jacob P.
    Bewley, Anthony
    Staender, Sonja
    Castro, Carla
    Misery, Laurent
    Kim, Brian S.
    Biswas, Pinaki
    Chan, Gary
    Myers, Daniela E.
    Watkins, Melissa
    Alderfer, Justine
    Gueler, Erman
    Silverberg, Jonathan I.
    [J]. DERMATOLOGY, 2024, 240 (02) : 255 - 265
  • [7] Dupilumab treatment induces rapid clinical improvement of itch in patients with moderate-to-severe atopic dermatitis
    Silverberg, Jonathan I.
    Eckert, Laurent
    Ardeleanu, Marius
    Chen, Zhen
    Akinlade, Bolanle
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozi, Gianluca
    Gadkari, Abhijit
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB113 - AB113
  • [8] Dupilumab elicits rapid and sustained improvements in itch in adults with moderate-to-severe atopic dermatitis
    Silverberg, J. I.
    Eckert, L.
    Yosipovitch, G.
    Kim, B.
    Simpson, E. L.
    Rossi, A. B.
    Ardeleanu, M.
    Chen, Z.
    Kaur, M.
    Gadkari, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S105 - S105
  • [9] EFFICACY OF ABROCITINIB AND DUPILUMAB IN PATIENTS WITH ITCH-DOMINANT ATOPIC DERMATITIS: A POOLED ANALYSIS OF 2 RANDOMIZED TRIALS
    Silverberg, Jonathan I.
    Thyssen, Jacob P.
    Lazariciu, Irina
    Valdez, Hernan
    Myers, Daniela E.
    Gueler, Erman
    Chovatiya, Raj
    [J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 31 - 32
  • [10] Efficacy and safety of abrocitinib in adolescent patients with moderate-to-severe atopic dermatitis: stratified analysis across three clinical trials
    Simpson, E.
    Lio, P.
    Heath, C.
    Boguniewicz, M.
    Levenberg, M.
    Biswas, P.
    Farooqui, S.
    Kerkmann, U.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E140 - E140
12345